Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GDC Coil Reduces Brain Aneurysm Mortality Risk v. Surgery, Study Finds

This article was originally published in The Gray Sheet

Executive Summary

Treatment of ruptured brain aneurysms with endovascular coils showed a substantial clinical benefit over conventional neurosurgery, according to a study published in the Oct. 25 issue of The Lancet

You may also be interested in...



J&J Will Extend Neuro Presence With $480 Million Micrus Acquisition

Johnson & Johnson's $480 million acquisition of Micrus Endovascular will expand its presence in the hemorrhagic stroke market and give the company a foothold in the high-promise ischemic stroke space

J&J Will Extend Neuro Presence With $480 Million Micrus Acquisition

Johnson & Johnson's $480 million acquisition of Micrus Endovascular will expand its presence in the hemorrhagic stroke market and give the company a foothold in the high-promise ischemic stroke space

Micrus IPO To Fund Japan Aneurysm Coil Market Entry, Bioactive Coil R&D

Micrus will establish a Japanese distribution network later this year with proceeds from an initial public offering of up to $57.5 mil. in common stock

Related Content

UsernamePublicRestriction

Register

LL1134478

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel